TY  - JOUR
AU  - Fernández, I.
AU  - Loinaz Segurola, Carmelo
AU  - Hernández, O.
AU  - Abradelo De Usera, Manuel
AU  - Manrique Municio, Alejandro
AU  - Calvo Pulido, Jorge
AU  - Manzano, M.
AU  - García, A.
AU  - Cambra Molero, Félix
AU  - Castellano Tortajada, Gregorio
AU  - Jiménez, C.
PY  - 2015
DO  - 10.1111/tid.12434
SN  - 1398-2273
UR  - https://hdl.handle.net/20.500.14352/116137
T2  - Transplant Infectious Disease
AB  - Background and aimsCombination of hepatitis B immunoglobulin (HBIG) and a nucleos(t)ide analog (NA) is considered the standard of care for prophylaxis of hepatitis B virus (HBV) recurrence after liver transplantation (LT). However, use of lifelong...
LA  - eng
M2  - 695
PB  - Wiley
KW  - entecavir
KW  - hepatitis B prophylaxis
KW  - hepatitis B recurrence
KW  - liver transplantation
KW  - nucleo(s)tide analog
KW  - tenofovir
TI  - Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients
TY  - journal article
VL  - 17
ER  -